W&T Offshore appoints Dr. Nancy Chang as independent director, effective April 28, 2023

W&T OFFSHORE INC

Board expanded to five members; Dr. Chang appointed to Audit and NCG Committees and as Chair of ESG Committee.
Dr. Chang previously CEO of Ansun Biopharma, co-founder/CEO of Tanox, and founder of Apex Capital; extensive board experience.
Will receive standard non-employee director compensation; entered into indemnification agreement with the company.
Press release issued May 1, 2023; Dr. Chang will stand for election at upcoming annual meeting.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Dr. Nancy Chang

Director

WTI · W&T OFFSHORE INC

Effective: 2023-04-28
Filed: May 1, 2023, 7:59 PM ET

On May 1, 2023, W&T Offshore, Inc. (the “Company”) announced that its Board of Directors (the “Board”), upon the recommendation of the Nominating and Corporate Governance Committee of the Board, voted to expand the size of the Board to five members and appointed Dr. Nancy Chang to fill the vacancy on the Board on April 28, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Dr. Nancy Chang was appointed as Director at W&T OFFSHORE INC.

Action: appointed
Role: Director

Exact text from the filing

On May 1, 2023, W&T Offshore, Inc. (the “Company”) announced that its Board of Directors (the “Board”), upon the recommendation of the Nominating and Corporate Governance Committee of the Board, voted to expand the size of the Board to five members and appointed Dr. Nancy Chang to fill the vacancy on the Board on April 28, 2023.

View on SEC.gov

W&T OFFSHORE INC filing history →

Source: SEC EDGAR

accession 0001104659-23-053458

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.